Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Nov-Dec;4(6):449-59.
doi: 10.2165/00003088-197904060-00004.

Dose-dependent elimination kinetics of theophylline

Dose-dependent elimination kinetics of theophylline

L J Lesko. Clin Pharmacokinet. 1979 Nov-Dec.

Abstract

There are an increasing number of clinical and experimental studies appearing in the literature suggesting that the elimination kinetics of theophylline may be dose-dependent in man. Evidence of nonlinearity includes observations that steady-state serum theophylline concentrations may increase disproportionately with increases in dose and that the elimination half-life of theophylline after multiple doses is longer than after single doses. Theophylline is apparently eliminated by parallel Michaelis-Menten and first-order kinetics. Although no specific studies of theophylline metabolism have been carried out to determine the causes of nonlinearity, it would appear that 1-demethylation of theophylline is a potentially saturable metabolic pathway. Dietary methylxanthines or their metabolites may influence the rate of elimination of theophylline and contribute to the causes of nonlinearity. Until the elimination kinetics of theophylline have been studied in more detail as a function of dose, it would seem prudent to increase doses of theophylline cautiously to minimise the risks of adverse side effects which might be associated with unexpected accumulation of theophylline.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Hosp Pharm. 1977 May;34(5):525-7 - PubMed
    1. J Pharm Sci. 1965 Jul;54(7):959-67 - PubMed
    1. Br J Clin Pharmacol. 1977 Oct;4(5):637P-638P - PubMed
    1. JAMA. 1976 May 10;235(19):2110-3 - PubMed
    1. Clin Pharmacol Ther. 1972 May-Jun;13(3):349-60 - PubMed

LinkOut - more resources